[go: up one dir, main page]

FR2900575B1 - Gel biocompatible a liberation controlee, son procede de preparation et son utilisation - Google Patents

Gel biocompatible a liberation controlee, son procede de preparation et son utilisation

Info

Publication number
FR2900575B1
FR2900575B1 FR0604068A FR0604068A FR2900575B1 FR 2900575 B1 FR2900575 B1 FR 2900575B1 FR 0604068 A FR0604068 A FR 0604068A FR 0604068 A FR0604068 A FR 0604068A FR 2900575 B1 FR2900575 B1 FR 2900575B1
Authority
FR
France
Prior art keywords
preparation
controlled release
release gel
biocompatible controlled
biocompatible
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0604068A
Other languages
English (en)
Other versions
FR2900575A1 (fr
Inventor
Laurence Hermitte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anteis SA
Original Assignee
Anteis SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anteis SA filed Critical Anteis SA
Priority to FR0604068A priority Critical patent/FR2900575B1/fr
Priority to PCT/FR2007/000781 priority patent/WO2007128923A2/fr
Publication of FR2900575A1 publication Critical patent/FR2900575A1/fr
Application granted granted Critical
Publication of FR2900575B1 publication Critical patent/FR2900575B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
FR0604068A 2006-05-05 2006-05-05 Gel biocompatible a liberation controlee, son procede de preparation et son utilisation Expired - Fee Related FR2900575B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0604068A FR2900575B1 (fr) 2006-05-05 2006-05-05 Gel biocompatible a liberation controlee, son procede de preparation et son utilisation
PCT/FR2007/000781 WO2007128923A2 (fr) 2006-05-05 2007-05-07 Procede de preparation d'un gel biocompatible a libération contrôlée d'un ou de plusieurs principes actifs peu solubles dans l'eau, gels ainsi obtenus et leur utilisation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0604068A FR2900575B1 (fr) 2006-05-05 2006-05-05 Gel biocompatible a liberation controlee, son procede de preparation et son utilisation

Publications (2)

Publication Number Publication Date
FR2900575A1 FR2900575A1 (fr) 2007-11-09
FR2900575B1 true FR2900575B1 (fr) 2008-10-17

Family

ID=37603377

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0604068A Expired - Fee Related FR2900575B1 (fr) 2006-05-05 2006-05-05 Gel biocompatible a liberation controlee, son procede de preparation et son utilisation

Country Status (2)

Country Link
FR (1) FR2900575B1 (fr)
WO (1) WO2007128923A2 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
CA2703109C (fr) 2007-11-16 2017-07-18 Vicept Therapeutics, Inc. Compositions et procedes de traitement du purpura
US8394782B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
FR2927255B1 (fr) * 2008-02-07 2011-08-12 Keysan Consulting Produits injectables biocompatibles a liberation de zinc et/ou de sel de saccharide sous forme de zinc et leurs utilisations.
US8450475B2 (en) * 2008-08-04 2013-05-28 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
AU2009288118B2 (en) 2008-09-02 2014-12-11 Allergan, Inc. Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
FR2938187B1 (fr) 2008-11-07 2012-08-17 Anteis Sa Composition injectable a base d'acide hyaluronique ou l'un de ses sels, de polyols et de lidocaine, sterilisee a la chaleur
WO2010069519A1 (fr) * 2008-12-18 2010-06-24 Merz Pharma Gmbh & Co. Kgaa Compositions topiques comprenant au moins un ingrédient actif difficilement soluble dans l'eau et des biopolymères, tels que l'acide hyaluronique, présentant une valeur pka située entre 5 et 7
FR2945949B1 (fr) 2009-05-26 2011-05-13 Anteis Sa Hydrogel injectable permettant une supplementation en glycerol dans la peau sur le long terme.
US9114188B2 (en) 2010-01-13 2015-08-25 Allergan, Industrie, S.A.S. Stable hydrogel compositions including additives
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
FR2957254B1 (fr) 2010-03-12 2016-10-14 Allergan Ind Sas Compositions fluides pour ameliorer les etats de la peau
CA2794254C (fr) 2010-03-22 2018-09-04 Allergan, Inc. Hydrogels reticules a base de polysaccharides et de proteines- polysaccharides pour l'augmentation des tissus mous
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
US8889123B2 (en) 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
KR102312056B1 (ko) 2011-06-03 2021-10-12 알러간 인더스트리 에스에이에스 항산화제를 포함하는 피부 충전제 조성물
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
ES2761558T3 (es) 2014-09-30 2020-05-20 Allergan Ind Sas Composiciones de hidrogel estables que incluyen aditivos
WO2016128783A1 (fr) 2015-02-09 2016-08-18 Allergan Industrie Sas Compositions et méthodes pour améliorer l'apparence de la peau
BR112017017346B1 (pt) 2015-02-13 2021-09-08 Allergan Industrie, Sas Composição estéril, implantável de modo subdérmico ou supraperiosteal na área de queixo, linha da mandíbula ou nariz, usos de uma quantidade eficaz de ácido hialurônico (ha) reticulado com bdde e kit
US10004824B2 (en) 2015-05-11 2018-06-26 Laboratoires Vivacy Compositions comprising at least one polyol and at least one anesthetic
FR3036035B1 (fr) 2015-05-11 2018-10-05 Laboratoires Vivacy Compositions comprenant au moins un polyol et au moins un anesthesique
FR3058064B1 (fr) 2016-10-28 2020-08-07 Lab Vivacy Composition a base d'acide hyaluronique comprenant de la mepivacaine
AU2019267711B2 (en) 2018-05-09 2025-04-17 The Johns Hopkins University Nanofiber-hydrogel composites for cell and tissue delivery
CA3099733A1 (fr) 2018-05-09 2019-11-14 The Johns Hopkins University Composites de nanofibres-hydrogel pour le remplacement et la regeneration ameliores de tissus mous
FR3111903B1 (fr) 2020-06-24 2022-12-02 Lab Vivacy Procede d’incorporation de composes organiques en solution au sein d’un hydrogel

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU570998B2 (en) * 1983-09-07 1988-03-31 Takeda Chemical Industries Ltd. Topical steroid compositions for acne
US5234914A (en) * 1991-06-11 1993-08-10 Patent Biopharmaceutics, Inc. Methods of treating hemorrhoids and anorecial disease
IT1313610B1 (it) * 1999-08-09 2002-09-09 S I F I Societa Ind Farmaceuti Processo per la preparazione di formulazioni acquose per uso oftalmico
WO2005039531A1 (fr) * 2003-10-10 2005-05-06 Antares Pharma Ipl Ag Formulation pharmaceutique transdermique visant a reduire les residus sur la peau
EP1325752A3 (fr) * 2000-08-03 2003-08-06 Antares Pharma IPL AG Composition pour l' administration percutanée et/ou par voie transmucosale de principes actifs assurant des niveaux d'efficacité thérapeutique adéquats
WO2002087563A2 (fr) * 2001-05-01 2002-11-07 Angiotech Pharmaceuticals Inc. Compositions et procedes pour le traitement d'etats inflammatoires par des proteines ou polysaccharides contenant des agents anti-microtubules
WO2003061626A1 (fr) * 2002-01-18 2003-07-31 Control Delivery Systems, Inc. Systeme de gel polymere pour administration regulee de medicaments combines
TR200201556A2 (tr) * 2002-06-12 2004-01-21 Orva İlaç Sanayi̇ Ve Ti̇caret A. Ş. Kortikosteroid ve nonsteroidal antienflamatuar içeren farmasötik bileşim
HUP0303313A2 (hu) * 2003-10-09 2005-07-28 Richter Gedeon Vegyészeti Gyár Rt. Transzdermális gyógyszerkészítmények
JP2007519756A (ja) * 2004-01-30 2007-07-19 アンジオテック インターナショナル アーゲー 拘縮を治療するための組成物および方法

Also Published As

Publication number Publication date
FR2900575A1 (fr) 2007-11-09
WO2007128923A2 (fr) 2007-11-15
WO2007128923A3 (fr) 2008-05-02

Similar Documents

Publication Publication Date Title
FR2900575B1 (fr) Gel biocompatible a liberation controlee, son procede de preparation et son utilisation
EP2298375A4 (fr) Dispositif de contrôle d'un coeur artificiel, système de coeur artificiel et procédé de contrôle d'un coeur artificiel
EP2124859A4 (fr) Dispositifs, systèmes et procédés permettant de raccourcir la durée des menstruations
IL205593A0 (en) Fecal incontinence device, system and method
EP2124835A4 (fr) Dispositif et procédé de retenue d'implant
BRPI0811846A2 (pt) Implante vertebral interespinhal, e, dispositivo
EP2297689A4 (fr) Dispositif, système et procédé de gestion automatique d instruments financiers
EP2046238A4 (fr) Système et procédé d'implant dentaire
EP2139432A4 (fr) Systèmes et procédés d'implant déformable
DE602006009682D1 (de) Knochenverankerungsvorrichtung
DE602006002105D1 (de) Knochenverankerungsvorrichtung
EP2011552A4 (fr) Système de gestion d'exercices, procédé de gestion d'exercices et programme de gestion d'exercices
BRPI0814523A2 (pt) Implante biocompatível, método para a formação do implante biocompatível e método de aplicação do mesmo
EP2214597A4 (fr) Implants rachidiens et procédés
IL208415A0 (en) Guided dental implantation system and associated device and method
DK2767265T3 (da) Justerbart implantatsystem
PL2205185T3 (pl) Urządzenie do wytwarzania zakotwiczenia w tkance ludzkiej lub zwierzęcej
PL2073864T3 (pl) Urządzenie i sposób odzyskiwania krwi
DE602008004191D1 (de) Knochenverankerungsvorrichtung
ZA201006081B (en) System and method for healing a wound at a tissue site
DE602006010556D1 (de) Knochenverankerungsvorrichtung
EP2355761A4 (fr) Dispositif, système et procédé de dimensionnement d'ouvertures tissulaires
EP2485682A4 (fr) Implant d'élément d'espacement de tissu, outil d'implantation, et leurs procédés d'utilisation
GB0919368D0 (en) Tissue embedding device, and method for the operation of a tissue embedding
EP2361045A4 (fr) Système chirurgical d'orientation et procédé associé

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20100129